acivicin has been researched along with Leishmaniasis, Visceral in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhaduri, A; Mukherjee, T; Roy, K | 1 |
1 other study(ies) available for acivicin and Leishmaniasis, Visceral
| Article | Year |
|---|---|
Acivicin: a highly active potential chemotherapeutic agent against visceral leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing); Cells, Cultured; Enzyme Activation; Isoxazoles; Leishmaniasis, Visceral; Mice; Mice, Inbred BALB C; Oxazoles | 1990 |